Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:35 PM
Ignite Modification Date:
2025-12-24 @ 11:35 PM
NCT ID:
NCT07144956
Eligibility Criteria:
Inclusion Criteria:
* Adult patients admitted to an ICU with SAH related to a ruptured cerebral aneurysm occurring within the last 96 hours.
* Aneurysm successfully secured by surgical clipping or endovascular coiling
* Consent of the patient or, if not possible, from a proxy (emergency clause).
* Registration in a national health care system
Exclusion Criteria:
* \- Precritical modified Rankin Scale (mRS) \> 2
* Nonaneurysmal SAH
* Delayed \>96h admission after first symptoms of SAH
* Coma defined by GCS of 3-5 with untreatable aneurysm will be excluded"
* Known allergy to cilostazol
* Pregnancy
* Pre-existing major hepatic, renal, pulmonary or cardiac disease
* Concomitant use of one other anti-platelet and/or anticoagulant agent
* SAH diagnosed on Lumbar puncture with no evidence of blood on CT.
* Tutelage or guardianship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07144956
Study Brief:
Protocol Section:
NCT07144956